Wed, 26 Feb 2020 08:00:00 GMT

MPM Capital Announces $100M Oncology Innovations Fund as Part of Novel Venture Philanthropy Collaboration with Dana-Farber Cancer Institute - Business Wire

Wed, 24 Feb 2021 08:00:00 GMT

Orna Therapeutics Launches with over $100M Raised to Develop a New Class of Fully Engineered Circular RNA Therapies - PR Newswire

Wed, 06 Oct 2021 07:00:00 GMT

MPM Capital Raises Biotech’s Largest Impact Investment Fund to Help Finance the Fight Against Cancer and Other Diseases - Business Wire

Tue, 16 Aug 2022 07:00:00 GMT

BioImpact Capital Announces a Multi-Billion Dollar Landmark Transaction in Vaccines and Cancer - Business Wire

Wed, 18 Nov 2020 08:00:00 GMT

Umoja Biopharma Launches with $53M Series A Financing to Develop Fully Integrated, Scalable, In Vivo Immunotherapy Platform - PR Newswire

Thu, 21 Feb 2019 08:00:00 GMT

MPM Capital Raises $400 Million to Fund Early-Stage Biotech Innovation - Business Wire

Mon, 18 Nov 2019 08:00:00 GMT

A leading global medicines company executes a strategic investment in SiO2 Medical Products gaining access to a potentially disruptive novel packaging technology - PR Newswire

Tue, 07 Dec 2021 08:00:00 GMT

MPM Capital Announces the Addition of Detlev Biniszkiewicz, Ph.D. to its Investment Committee - Business Wire

Wed, 07 Apr 2021 07:00:00 GMT

MPM Capital Strengthens Team with the Addition of Neuroscience R&D Leader David S. Bredt, MD, PhD as Executive Partner - Business Wire